EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia–Reperfusion Injury: A Serum Pharmaco‐Chemistry With Network Pharmacology Analysis

Weisong Wang iD, Zengyu Zhang iD, Rongzhen Liu, Yu Zheng, Yaqi Hu, Xia Li, Zihao Shen, Hengyou Yuan, Jianhe Liu iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Weisong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Network Pharmacology, Myocardial Reperfusion Injury, Drugs, Chinese Herbal, Phytochemicals. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Second Batch Leading Talents and Acdemic Leaders Training Projects of Chinese Medicine of Hunan Province in the 14th Five-Year Plan, Double First-Class Discipline Construction-Research on Prevention and Treatment of Cardio-Cerebral Diseases by Traditional Chinese Medicine, Changsha Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have shown the potential of Chaihu Sanshen capsule (CHSSC) to ameliorate myocardial ischemia‐reperfusion injury (MIRI), but there is yet no corresponding research on its chemical ingredients and multi‐target action network. The study aims to identify the chemical composition and potential bioactive compounds of CHSSC and elucidate its underlying mechanisms in MIRI treatment. Ultra‐high‐performance liquid chromatography‐Q exactive focus‐mass spectrometry was used to analyse the chemical composition and potential bioactive compounds of CHSSC. The active compounds were analysed via network pharmacology to identify the core targets and pathways. The oxygen–glucose deprivation/reoxygenation (OGD/R) H9C2 cell model and MIRI rat model were established, followed by intervention with CHSSC. TUNEL, flow cytometry and western blotting assays were used to observe the effects of CHSSC on apoptosis, pyroptosis and the PI3K/AKT/p53 signalling pathway, respectively, of cardiomyocytes. In all, 1587 compounds were detected in CHSSC, of which 106 were absorbed into the bloodstream, mainly comprising flavonoids, terpenoids, alkaloids, organic acids, coumarins and phenols. CHSSC primarily targeted TP53, AKT, STAT3, HSP90AA1 and MAPK and involved the regulation of p53, PI3K/AKT, JAK2/STAT3 and MAPK signalling pathways; however, these predicted targets have not yet been validated by confirmatory binding assays. In vitro experiments showed that CHSSC reduced the apoptosis and pyroptosis rates of OGD/R H9C2 cells. In vivo, CHSSC ameliorated myocardial injury in MIRI rats, decreased the cardiomyocyte apoptosis rate, increased PI3K and AKT phosphorylation and inhibited p53 phosphorylation. In conclusion, this study elucidated the potential bioactive compounds and multi‐targets action network of CHSSC in mitigating MIRI, and verified that the effects of CHSSC on MIRI are link to the PI3K/AKT/p53 signalling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyMyocardial Reperfusion InjuryDrugs, Chinese HerbalPhytochemicalsAnimalsRatsApoptosisMyocytes, CardiacSignal TransductionMaleRats, Sprague-DawleyCell LineCapsulesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesDisease Models, Animal

Stichwörter der Autor:innen

Chaihu Sanshen capsulePI3k/Akt/p53 signalling pathwaymyocardial ischaemia–reperfusion injurynetwork pharmacologyserum pharmaco‐chemistry

Substanzen

Drugs, Chinese HerbalCapsulesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPhytochemicals

Autor:innen und Institutionen

  • Department of Cardiology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
  • Research Center for Clinical Medicine, Jinshan Hospital Affiliated to Fudan University, Shanghai, China.
  • Literature and Information Research Institute, Hunan Academy of Chinese Medicine, Changsha, Hunan, China.
  • Department of Respiratory Diseases, Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, China.
  • Laboratory of Vascular Biology and Translational Medicine, Medical School, Hunan University of Chinese Medicine, Changsha, Hunan, China.
  • Xiangxing College, Hunan University of Chinese Medicine, Changsha, Hunan, China.

ORCID-Profile: Weisong Wang, Zengyu Zhang, Jianhe Liu

Förderung

  • Second Batch Leading Talents and Acdemic Leaders Training Projects of Chinese Medicine of Hunan Province in the 14th Five-Year Plan
  • Double First-Class Discipline Construction-Research on Prevention and Treatment of Cardio-Cerebral Diseases by Traditional Chinese Medicine
  • Changsha Natural Science Foundation Project
  • Provincial Financed Project for Traditional Chinese Medicine
  • Key Project of the Scientific Research Plan of the Administration of Traditional Chinese Medicine of Hunan Province
  • Key Scientific Research Project of the Education Department of Hunan Province

Zitieren

APA

Wang, W., Zhang, Z., Liu, R., Zheng, Y., Hu, Y., Li, X., Shen, Z., Yuan, H., & Liu, J. (2025). Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia–Reperfusion Injury: A Serum Pharmaco‐Chemistry With Network Pharmacology Analysis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70666

Vancouver

Wang W, Zhang Z, Liu R, Zheng Y, Hu Y, Li X, et al. Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia–Reperfusion Injury: A Serum Pharmaco‐Chemistry With Network Pharmacology Analysis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70666

BibTeX
@article{Wang2025,
  author = {Wang, Weisong and Zhang, Zengyu and Liu, Rongzhen and Zheng, Yu and Hu, Yaqi and Li, Xia and Shen, Zihao and Yuan, Hengyou and Liu, Jianhe},
  title = {Exploration of the Potential Bioactive Compounds and Functional Mechanism of Chaihu Sanshen Capsule in Ameliorating Myocardial Ischaemia–Reperfusion Injury: A Serum Pharmaco‐Chemistry With Network Pharmacology Analysis},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70666}
}
Kostenlos starten →